These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1893830)

  • 1. [The isolation of the NH2-terminal disulfide nodes of human fibrinogen and fibrin and of their constituent polypeptide chain fragments].
    Chudnovets VS; Lugovskoĭ EV; Gogolinskaia GK; Derzskaia SG; Nazimov IV; Komissarenko SV
    Dokl Akad Nauk SSSR; 1991; 317(6):1496-9. PubMed ID: 1893830
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of fibrinogen A alpha-chain by affinity chromatography on concanavalin A-sepharose.
    Bögli C; Hofer A; Furlan M
    Thromb Haemost; 1988 Oct; 60(2):308-10. PubMed ID: 3217923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 4. On the identity of fibrin(ogen) oligomers appearing during fibrin polymerization.
    Henschen A
    Adv Exp Med Biol; 1990; 281():49-53. PubMed ID: 2102625
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonrandom catabolism of proteins in the formation of antigenic peptide fragments.
    Thomas DW; Schauster JL; Hoffman MD; Wilner GD
    J Immunol; 1985 Aug; 135(2):1259-63. PubMed ID: 3874235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the structure of canine fibrinogen.
    Birken S; Wilner GD; Canfield RE
    Thromb Res; 1975 Oct; 7(4):599-610. PubMed ID: 1198547
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification of human fibrinopeptides by high-performance liquid chromatography.
    Koehn JA; Canfield RE
    Anal Biochem; 1981 Sep; 116(2):349-56. PubMed ID: 7316166
    [No Abstract]   [Full Text] [Related]  

  • 9. Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42.
    Hamaguchi M; Bunce LA; Sporn LA; Francis CW
    Blood; 1993 May; 81(9):2348-56. PubMed ID: 8481515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal and fibrinaemic patient plasma contain high-molecular weight crosslinked fibrin(ogen) derivatives with intact fibrinopeptide A.
    Grøn B; Bennick A; Nieuwenhuizen W; Brosstad F
    Thromb Res; 1990 Jan; 57(2):259-70. PubMed ID: 2315888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinogen and fibrinogenesis].
    Matthias FR
    Med Welt; 1975 Sep; 26(39):1786-9. PubMed ID: 1100992
    [No Abstract]   [Full Text] [Related]  

  • 12. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
    Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
    Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
    Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM; Mullin JL; Lord ST
    Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
    Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation.
    Halvorsen S; Skjønsberg OH; Godal HC
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):133-7. PubMed ID: 8457641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunovisualization of fibrinogen A alpha-chain heterogeneity in normal plasma and plasma from patients with DIC or on streptokinase therapy.
    Grøn B; Bennick A; Nieuwenhuizen W; Bjørnsen S; Brosstad F
    Thromb Res; 1988 Dec; 52(5):413-24. PubMed ID: 3222783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation and identification of N-terminal fragments of the A-alpha chain of bovine fibrinogen].
    Pekhnik IV; Kheĭlomskiĭ AB; Chikurova EV
    Ukr Biokhim Zh (1978); 1991; 63(2):3-8. PubMed ID: 1882460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
    Francis CW; Bunce LA; Sporn LA
    Blood Cells; 1993; 19(2):291-306; discussion 306-7. PubMed ID: 8312565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
    McCulloch P; Douglas J; Lowe GD; Murray G; George WD
    Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.